Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

NCT00967174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Nicotine Patch
DRUG: Placebo Patch
DRUG: SLS Comparator Patch

Sponsor

McNeil AB